Hu X, Wang G, Cheng H. Specific antigens in malignancy-associated membranous nephropathy. Front Med (Lausanne). 2024. https://doi.org/10.3389/fmed.2024.1368457.

Article  PubMed  PubMed Central  Google Scholar 

Storrar J, Gill-Taylor T, Chinnadurai R, Chrysochou C, Poulikakos D, Rainone F, et al. A low rate of end-stage kidney disease in membranous nephropathy: a single centre study over 2 decades. PLoS ONE. 2022. https://doi.org/10.1371/journal.pone.0276053.

Article  PubMed  PubMed Central  Google Scholar 

Jiang Z, Cai M, Dong B, Yan Y, Wang Y, Li X, et al. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study. BMC Nephrol. 2021. https://doi.org/10.1186/s12882-021-02348-4.

Article  PubMed  PubMed Central  Google Scholar 

Hoxha E, Reinhard L, Stahl R. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 2022. https://doi.org/10.1038/s41581-022-00564-1.

Article  PubMed  Google Scholar 

Sethi S, Glassock RJ, Haas M, Vriese ASD, Caza TN, Hoxha E, et al. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Mayo Clin Proc. 2023. https://doi.org/10.1016/j.mayocp.2023.08.006.

Article  PubMed  Google Scholar 

Leeaphorn N, Kue APP, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL. Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol. 2014. https://doi.org/10.1159/000364782.

Article  PubMed  Google Scholar 

Schwartz MM. Membranous glomerulonephritis. In: Little RH, editor. Pathology of the kidney. 4th ed. Boston: Little Brown and Company; 1992. p. 559–626.

Google Scholar 

Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 1997. https://doi.org/10.1038/ki.1997.32.

Article  PubMed  Google Scholar 

Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int. 1983. https://doi.org/10.1038/ki.1983.170.

Article  PubMed  Google Scholar 

WHO. Classification of Tumours Editorial Board. In: WHO classification of tumours: digestive system tumours. 5th ed. Lyon: IARC; 2019.

Google Scholar 

Lee CJ, Yamauchi H, Hopper J. The association of cancer and the nephrotic syndrome. Ann Intern Med. 1966. https://doi.org/10.7326/0003-4819-64-1-41.

Article  PubMed  Google Scholar 

Radhakrishnan Y, Zand L, Sethi S, Fervenza FC. Membranous nephropathy treatment standard. Nephrol Dial Transplant. 2024. https://doi.org/10.1093/ndt/gfad225.

Article  PubMed  Google Scholar 

Kuo MW, Wang CH, Wu HC, Chang SJ, Chuang YJ. Soluble THSD7A Is an N-glycoprotein that promotes endothelial cell migration and tube formation in angiogenesis. PLoS ONE. 2011. https://doi.org/10.1371/journal.pone.0029000.

Article  PubMed  PubMed Central  Google Scholar 

Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014. https://doi.org/10.1056/NEJMoa1409354.

Article  PubMed  PubMed Central  Google Scholar 

Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, et al. Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 2006. https://doi.org/10.1038/sj.ki.5001790.

Article  PubMed  Google Scholar 

Hoxha E, Wiech T, Stahl PR, Zahner G, Tomas NM, Meyer-Schwesinger C, et al. A mechanism for cancer-associated membranous nephropathy. N Engl J Med. 2016. https://doi.org/10.1056/NEJMc1511702.

Article  PubMed  Google Scholar 

Xu QQ, Zou GM, Zhuo L, Gao HM, Li WG. Lung cancer patients with nephropathy as the first manifestation: literature review and clinical study report. Front Oncol. 2022. https://doi.org/10.3389/fonc.2022.1002155.

Article  PubMed  PubMed Central  Google Scholar 

Haxthausen F, Reinhard L, Pinnschmidt HO, Rink M, Soave A, Hoxha E, et al. Antigen-specific IgG subclasses in primary and malignancy-associated membranous nephropathy. Front Immunol. 2018. https://doi.org/10.3389/fimmu.2018.03035.

Article  Google Scholar 

Taguchi S, Koshikawa Y, Ohyama S, Miyachi H, Ozawa H, Asada H. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report. BMC Nephrol. 2019. https://doi.org/10.1186/s12882-019-1236-y.

Article  PubMed  PubMed Central  Google Scholar 

Lin FJ, Zhang D, Chang J, Tang XL, Guan WB, Jiang GR, et al. THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1. Eur J Med Genet. 2018. https://doi.org/10.1016/j.ejmg.2017.10.014.

Article  PubMed  Google Scholar 

Takeuchi C, Yamashita S, Liu YY, Takeshima H, Sasaki A, Fukuda M, et al. Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation. Gut. 2024. https://doi.org/10.1136/gutjnl-2023-329492.

Article  PubMed  Google Scholar 

Shen K, Chen B, Yang L, Gao W. Integrated analysis of single-cell and bulk RNA-sequencing data reveals the prognostic value and molecular function of THSD7A in gastric cancer. Aging. 2023. https://doi.org/10.18632/aging.205158.

Article  PubMed  PubMed Central  Google Scholar